EDAP TMS (EDAP) Expected to Announce Earnings on Thursday

Key Points

• Edap Tms is set to announce its Q2 2025 earnings on August 28, with analysts predicting a loss of ($0.18) per share and revenues of approximately $16.6 million.
• The company's stock price has declined by 7.1%, currently sitting at $1.3750, and has an average rating of "Hold" from analysts with a consensus price target of $8.50.
• Piper Sandler recently downgraded Edap Tms from an "overweight" to a "neutral" rating, reflecting a shift in market sentiment towards the stock.

EDAP TMS (NASDAQ:EDAP - Get Free Report) is projected to announce its Q2 2025 results before the market opens on Thursday, August 28th. Analysts expect the company to announce earnings of ($0.18) per share and revenue of $16.5970 million for the quarter. Individuals may visit the the company's upcoming Q2 2025 earningresults page for the latest details on the call scheduled for Thursday, August 28, 2025 at 8:30 AM ET.

EDAP TMS Stock Down 0.4%

Shares of EDAP stock traded down $0.0050 during midday trading on Monday, reaching $1.3450. 62,180 shares of the stock were exchanged, compared to its average volume of 78,831. EDAP TMS has a 1 year low of $1.21 and a 1 year high of $4.22. The company's 50 day moving average is $1.50 and its two-hundred day moving average is $1.86. The company has a current ratio of 1.74, a quick ratio of 1.21 and a debt-to-equity ratio of 0.10. The firm has a market cap of $50.29 million, a PE ratio of -2.17 and a beta of -0.09.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the company. Wall Street Zen assumed coverage on EDAP TMS in a report on Thursday, May 15th. They set a "hold" rating on the stock. Piper Sandler downgraded EDAP TMS from an "overweight" rating to a "neutral" rating in a research note on Thursday, May 15th. One research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $8.50.

EDAP TMS Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.